Clinical Outcome of Hyperuricemia in IgA Nephropathy: A Retrospective Cohort Study and Randomized Controlled Trial
- 23 November 2011
- journal article
- research article
- Published by S. Karger AG in Kidney and Blood Pressure Research
- Vol. 35 (3), 153-160
- https://doi.org/10.1159/000331453
Abstract
Background: Hyperuricemia is an independent risk factor for renal progression in IgA nephropathy (IgAN). However, no study has evaluated the effect of allopurinol on the clinical outcome in hyperuricemic IgAN. Methods: First,a retrospective cohort study of 353 IgAN patients was conducted to explore the relationship between uric acid (UA) and the progression of renal disease over a mean period of 5 years. Then, 40 hyperuricemic IgAN patients were randomized to receive allopurinol (100–300 mg/day) or usual therapy for 6 months. The study outcomes were renal disease progression and/or blood pressure. Results: Hyperuricemia independently predicted renal survival at 1, 3, and 5 years after adjustment for different baseline estimated glomerular filtration rates. In the randomized controlled trial, allopurinol did not significantly alter renal progression or proteinuria. The antihypertensive drug dosage was reduced in 7 of 9 cases with hypertension in the allopurinol group compared to 0 of 9 cases in the control group (p < 0.01). UA levels correlated with mean arterial pressure in normotensive patients (r = 0.388, p < 0.001). Conclusion: Hyperuricemia predicts the progression of IgAN independently of baseline estimated glomerular filtration rate. Allopurinol may improve the control of blood pressure. Further studies are required to explore the effects of lowering UA on renal protection in IgAN.Keywords
This publication has 24 references indexed in Scilit:
- Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular RiskClinical Journal of the American Society of Nephrology, 2010
- Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cellsAmerican Journal of Physiology-Cell Physiology, 2008
- Uric acid stimulates endothelin-1 gene expression associated with NADPH oxidase in human aortic smooth muscle cellsActa Pharmacologica Sinica, 2008
- Uric Acid and Cardiovascular RiskThe New England Journal of Medicine, 2008
- Inactivation of Nitric Oxide by Uric AcidNucleosides, Nucleotides and Nucleic Acids, 2008
- Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin–angiotensin systemJournal of Hypertension, 2008
- Improved GFR estimation by combined creatinine and cystatin C measurementsKidney International, 2007
- Use of Allopurinol in Slowing the Progression of Renal Disease Through Its Ability to Lower Serum Uric Acid LevelAmerican Journal of Kidney Diseases, 2006
- Uric acid and the state of the intrarenal renin-angiotensin system in humansKidney International, 2004
- Uric Acid Stimulates Monocyte Chemoattractant Protein-1 Production in Vascular Smooth Muscle Cells Via Mitogen-Activated Protein Kinase and Cyclooxygenase-2Hypertension, 2003